Código QR

Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector

The COVID-19 pandemic emerged in 2020 and has caused an unprecedented burden to all countries in the world. SARS-CoV-2 continues to circulate and antigenically evolve, enabling multiple reinfections. To address the issue of the virus antigenic variability, T cell-based vaccines are being developed,...

ver descrição completa

Na minha lista:
Principais autores: Irina Isakova-Sivak, Ekaterina Stepanova, Victoria Matyushenko, Sergei Niskanen, Daria Mezhenskaya, Ekaterina Bazhenova, Elena Krutikova, Tatiana Kotomina, Polina Prokopenko, Bogdan Neterebskii, Aleksandr Doronin, Elena Vinogradova, Kirill Yakovlev, Konstantin Sivak, Larisa Rudenko
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2022-07-01
Colecção:Vaccines
Assuntos:
SARS-CoV-2
COVID-19 vaccine
influenza virus vector
live attenuated influenza vaccine
T-cell epitopes
HLA-A2.1 transgenic mice
Acesso em linha:https://www.mdpi.com/2076-393X/10/7/1142
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados